Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function.
about
TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor MilieuIdentifying Individual T Cell Receptors of Optimal Avidity for Tumor AntigensGenetically modified T cells in cancer therapy: opportunities and challengesT-cell receptor gene therapy--ready to go viral?Smart CARs engineered for cancer immunotherapyEcological analysis of antigen-specific CTL repertoires defines the relationship between naive and immune T-cell populationsPolarized alloantigen presentation by airway epithelial cells contributes to direct CD8+ T cell activation in the airway.Identification of multiple public TCR repertoires in chronic beryllium disease.T cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth.TCRep 3D: an automated in silico approach to study the structural properties of TCR repertoires.T cell avidity and tumor immunity: problems and solutionsProfile of a serial killer: cellular and molecular approaches to study individual cytotoxic T-cells following therapeutic vaccination.Specific increase in potency via structure-based design of a TCR.Peptide-pulsed dendritic cells have superior ability to induce immune-mediated tissue destruction compared to peptide with adjuvantSpecific roles of each TCR hemichain in generating functional chain-centric TCR.T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cellsCorrelating RANK ligand/RANK binding kinetics with osteoclast formation and functionMultiformat T-cell-engaging bispecific antibodies targeting human breast cancers.TCR affinity and specificity requirements for human regulatory T-cell functionChimeric antigen receptor-engineered T cells for the treatment of metastatic prostate cancer.Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in MiceInterplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness.Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death.Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrenceSHP-1 phosphatase activity counteracts increased T cell receptor affinity.CD4(+) and CD8(+) TCRβ repertoires possess different potentials to generate extraordinarily high-avidity T cells.T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapyEnhanced-affinity murine T-cell receptors for tumor/self-antigens can be safe in gene therapy despite surpassing the threshold for thymic selection.Role of T cell receptor affinity in the efficacy and specificity of adoptive T cell therapies.Structure-Based, Rational Design of T Cell Receptors.MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancerArchitecture of a minimal signaling pathway explains the T-cell response to a 1 million-fold variation in antigen affinity and dose.Enhancement of tumor-reactive cytotoxic CD4+ T cell responses after ipilimumab treatment in four advanced melanoma patients.Transnuclear TRP1-specific CD8 T cells with high or low affinity TCRs show equivalent antitumor activity.Reproducible selection of high avidity CD8+ T-cell clones following secondary acute virus infection.2D TCR-pMHC-CD8 kinetics determines T-cell responses in a self-antigen-specific TCR system.Antigen-driven T-cell repertoire selection during adaptive immune responses.Structural and biophysical determinants of αβ T-cell antigen recognition.T-cell-receptor-like antibodies - generation, function and applications.Uncovering new aspects of protein interactions through analysis of specificity landscapes in peptide recognition domains.
P2860
Q21131200-D085540C-C515-471A-94AB-3C57A980B220Q26774669-0C960273-08FE-4C85-8EFC-D1489BC57010Q27026627-BCF594A1-9351-42DF-8526-8565AFA7F3FCQ28081611-1AB19AAA-618B-4446-9B37-72BE07203A40Q28087236-25B3D703-875B-4355-82ED-21D28751C28BQ28709263-73660128-8ADB-4131-B2D3-73D9251E73EBQ30502451-5A28AC67-3F7C-45FF-886B-5F78F45EC2BBQ33573915-19531D04-A66D-47AD-A8C7-17CF3CA1B3D5Q33632100-417A0C83-3D96-4FD0-BC37-CD91FF27E334Q34066957-EDB5FF51-D996-4C1F-90D1-1C618419E2DBQ34115960-31316D3E-9CA8-442D-9B5C-940B1A3D8B17Q34338725-8D2230B6-78B9-42FB-A13B-BD17B1C4789CQ34383054-892E4707-781A-4E70-9C11-8311965DC085Q35125382-2308D083-0915-4645-8695-C2B511FE209EQ35205495-5638D9A4-69BB-45AB-845D-34CDFCE125FFQ35533181-90F2C1D4-D55E-4E73-A226-82029563198FQ35599724-6C8C7C56-6D71-45F7-8AEA-AE5CC7E79266Q35822172-4FE15082-5755-4867-B8B5-64B4F25611FCQ35885273-7AFFED17-7C6C-4499-879C-F0925CB7B85DQ35980893-85624F92-48F7-4FE3-BB00-3DA03151494FQ36028047-8D208588-AD1F-4C2F-988A-9D9E9C981369Q36080586-239C1937-E20A-4901-87A4-E90292F1CFECQ36301061-3C4C17DF-96D4-4084-97C0-22917C2E60B2Q36555546-B6C92737-D21D-4E3D-B19C-6B0BEE0B0976Q36638160-3D693CC2-2B90-4B74-85F7-DE19C1063087Q36748257-8EB367A9-7E6E-4F8B-94C0-7996744AE48DQ36799229-DFA6F1E1-B0A3-4AE9-ACB6-6AB335AD9B1EQ37026759-D914A7EB-6ADD-4DC6-A8EE-8246B79E4FD9Q37107843-3D175937-AA5C-4217-AA92-D771183D58E0Q37165240-7E0AC2BF-AC56-40B1-A433-26400EC1F3DCQ37210788-14B7A87F-9C57-4F8D-A2C3-C54225898003Q37379865-20A1E30F-4C4D-46CD-BCE3-E369C790977EQ37430286-5EB903F5-76D4-47E4-93D5-558869154F92Q37494158-64EC416E-F51B-4310-8066-255FDF135227Q37544031-E7D4DE5E-472C-4170-BBA9-CB018EE63A5FQ37614812-93FB0367-7934-4E7F-9734-E7FA2323AD31Q37801271-4CE9B1CE-B38F-4F00-BC56-52C717D67A3BQ37951560-1826D1FC-B6E2-4BD3-BAFD-4D8BBE131E2DQ37987723-330B0ACC-882F-4D79-B895-9E9E0537387BQ38019706-D0DF0B93-7757-4530-B0A7-0D7A156D5921
P2860
Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function.
@en
Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function.
@nl
type
label
Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function.
@en
Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function.
@nl
prefLabel
Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function.
@en
Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function.
@nl
P2093
P356
P1476
Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function
@en
P2093
Anita Posevitz-Fejfar
Daniel E Speiser
Daphné A Schmid
J-C Floyd Sarria
Melita B Irving
Michael Hebeisen
Nathalie Rufer
Olivier Michielin
Pedro Romero
Raquel Gomez-Eerland
P304
P356
10.4049/JIMMUNOL.1000173
P407
P50
P577
2010-03-29T00:00:00Z